AMD stock has declined in 2026, despite strong revenue growth and accelerating demand for its AI chips. AI infrastructure deals with Meta and OpenAI have improved AMD’s long-term revenue visibility.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A hot potato: A year after announcing the most significant change to Android in a long time, Google is now introducing a new process aimed at making the mobile platform "open" again. Mountain View ...
The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...
Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...
Congress is currently divided over the implementation of new, mandatory anti-drunk driving technology—and now, federal safety regulators are weighing in with a report that casts doubt on the timeline ...
Leveraging deep learning for immersive 3D visualization, integrated CT imaging workflows and enhanced precision in lung navigation and surgical planning SAN JOSE ...
The U.S. Navy has set an aggressive timeline and cost goal for its next-generation trainer, and will keep its plan to no longer require carrier-representative unflared landings to meet it. The service ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...
There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...
Axsome's (AXSM-0.50%) revenue is soaring thanks to strong momentum for two drugs -- Auvelity and Sunosi. The company launched Auvelity in October 2022 as a treatment for major depressive disorder. It ...